GlassScriptPhysician profile
Lynda E Bockmon
NPI 1609089481
$1,772.94
in general payments reported to CMS, 2019-2025
28 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $649 · 2022: $448 · 2023: $255 · 2024: $203 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $437.10 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $236.22 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $176.48 | 2021-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $132.81 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $121.55 | 2022 | |
| Bard Peripheral Vascular, INC. | $117.67 | 2021-2023 | Lutonix Drug Coated Balloon |
| Genzyme Corporation | $58.82 | 2025 | |
| Boston Scientific Corporation | $45.35 | 2023 | Varithena Administration Pack |
| Pacira Pharmaceuticals Incorporated | $35.79 | 2021 | |
| Cordis US Corp. | $34.13 | 2024 | S.M.A.R.T. Control |
| Angiodynamics, INC. | $33.88 | 2021-2022 | |
| Pfizer INC. | $30.20 | 2021-2023 | |
| Surmodics, INC. | $28.63 | 2022-2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Regeneron Healthcare Solutions, INC. | $26.88 | 2025 | Dupixent |
| Kerecis Limited | $25.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $22.72 | 2022 | |
| Viatris Specialty LLC | $22.30 | 2025 | Yupelri |
| Stryker Corporation | $21.70 | 2025 | Artix Mt |
| Amgen INC. | $21.41 | 2025 | Tezspire |
| Astrazeneca Pharmaceuticals LP | $20.86 | 2025 | Breztri |
| Kci USA, INC. | $18.83 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.79 | 2023 | Eliquis |
| Polynovo North America LLC | $17.43 | 2024 | Novosorb Btm |
| Abbvie INC. | $16.01 | 2022 | |
| Getinge USA Sales, LLC | $15.65 | 2021 | |
| Glaxosmithkline, LLC. | $14.62 | 2025 | Trelegy Ellipta |
| Teleflex LLC | $11.52 | 2021 | |
| Convatec INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynda Bockmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.